{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T04:49:10Z","timestamp":1791434950167,"version":"4.3.3"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:00:00Z","timestamp":1784073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:00:00Z","timestamp":1791417600000},"content-version":"vor","delay-in-days":85,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82304023"],"award-info":[{"award-number":["82304023"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82404171"],"award-info":[{"award-number":["82404171"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammation"],"DOI":"10.1007\/s10753-026-02570-y","type":"journal-article","created":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T02:47:17Z","timestamp":1784083637000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Interleukin 32 Exacerbates Vitiligo by Promoting Inflammation and Oxidative Stress-induced Injury in Melanocytes"],"prefix":"10.1007","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3405-9580","authenticated-orcid":false,"given":"Tianqi","family":"Wei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baiyi","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaokang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beilei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingling","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengrang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,15]]},"reference":[{"key":"2570_CR1","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s12016-021-08868-z","volume":"61","author":"Y Wang","year":"2021","unstructured":"Wang, Y., S. Li, and C. Li. 2021. Clinical Features, Immunopathogenesis, and Therapeutic Strategies in Vitiligo. Clinical Reviews In Allergy And Immunology 61:299\u2013323.","journal-title":"Clinical Reviews In Allergy And Immunology"},{"key":"2570_CR2","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1007\/s40257-021-00631-6","volume":"22","author":"K Ezzedine","year":"2021","unstructured":"Ezzedine, K., V. Eleftheriadou, H. Jones, K. Bibeau, F.I. Kuo, D. Sturm, and A.G. Pandya. 2021. Psychosocial effects of vitiligo: A systematic literature review. American Journal of Clinical Dermatology 22: 757\u2013774.","journal-title":"American Journal of Clinical Dermatology"},{"key":"2570_CR3","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.det.2016.11.014","volume":"35","author":"M Rashighi","year":"2017","unstructured":"Rashighi, M., and J. E. Harris. 2017. Vitiligo Pathogenesis and Emerging Treatments. Dermatologic Clinics 35:257\u2013265.","journal-title":"Dermatologic Clinics"},{"key":"2570_CR4","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.coi.2013.10.010","volume":"25","author":"JM Richmond","year":"2013","unstructured":"Richmond, J.M., M.L. Frisoli, and J.E. Harris. 2013. Innate immune mechanisms in vitiligo: Danger from within. Current Opinion in Immunology 25: 676\u2013682.","journal-title":"Current Opinion in Immunology"},{"key":"2570_CR5","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1007\/s40291-023-00672-z","volume":"27","author":"A Bialczyk","year":"2023","unstructured":"Bialczyk, A., A. Welniak, B. Kaminska, and R. Czajkowski. 2023. Oxidative Stress and Potential Antioxidant Therapies in Vitiligo: A Narrative Review. Molecular Diagnosis & Therapy 27:723\u2013739.","journal-title":"Molecular Diagnosis & Therapy"},{"key":"2570_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.freeradbiomed.2025.09.018","volume":"241","author":"R Gao","year":"2025","unstructured":"Gao, R., D. Meng, Z. Zhao, H. Xue, N. Hu, P. Jiang, W. Yu, W. Xu, C. Yin, H. Zhang, and J. Lv. 2025. VDAC1 oligomerization-mediated mtDNA release under sublethal oxidative stress: A novel inflammatory mechanism in vitiligo. Free Radical Biology And Medicine 241:1\u201313.","journal-title":"Free Radical Biology And Medicine"},{"key":"2570_CR7","doi-asserted-by":"publisher","first-page":"e2250281","DOI":"10.1002\/eji.202250281","volume":"54","author":"H Liu","year":"2024","unstructured":"Liu, H., Y. Wang, Q. Le, J. Tong, and H. Wang. 2024. The IFN-gamma-CXCL9\/CXCL10-CXCR3 axis in vitiligo: Pathological mechanism and treatment. European Journal Of Immunology 54:e2250281.","journal-title":"European Journal Of Immunology"},{"key":"2570_CR8","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1038\/s41586-021-04221-8","volume":"601","author":"Z Xu","year":"2022","unstructured":"Xu, Z., D. Chen, Y. Hu, K. Jiang, H. Huang, Y. Du, W. Wu, J. Wang, J. Sui, W. Wang, L. Zhang, S. Li, C. Li, Y. Yang, J. Chang, and T. Chen. 2022. Anatomically distinct fibroblast subsets determine skin autoimmune patterns. Nature 601:118\u2013124.","journal-title":"Nature"},{"key":"2570_CR9","doi-asserted-by":"publisher","first-page":"597","DOI":"10.4049\/jimmunol.148.2.597","volume":"148","author":"CA Dahl","year":"1992","unstructured":"Dahl, C. A., R. P. Schall, H. L. He, and J. S. Cairns. 1992. Identification of a novel gene expressed in activated natural killer cells and T cells. The Journal Of Immunology 148:597\u2013603.","journal-title":"The Journal Of Immunology"},{"key":"2570_CR10","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1002\/JLB.3MR0620-550R","volume":"109","author":"KR Aass","year":"2021","unstructured":"Aass, K. R., M. H. Kastnes, and T. Standal. 2021. Molecular interactions and functions of IL-32. Journal Of Leukocyte Biology 109:143\u2013159.","journal-title":"Journal Of Leukocyte Biology"},{"key":"2570_CR11","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.pharmthera.2017.02.025","volume":"174","author":"JT Hong","year":"2017","unstructured":"Hong, J.T., D.J. Son, C.K. Lee, D.Y. Yoon, D.H. Lee, and M.H. Park. 2017. Interleukin 32, inflammation and cancer. Pharmacology & Therapeutics 174: 127\u2013137.","journal-title":"Pharmacology & Therapeutics"},{"key":"2570_CR12","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.smim.2018.03.004","volume":"38","author":"YJE Sloot","year":"2018","unstructured":"Sloot, Y. J. E., J. W. Smit, L. A. B. Joosten, and R. T. Netea-Maier. 2018. Insights into the role of IL-32 in cancer. Seminars In Immunology 38:24\u201332.","journal-title":"Seminars In Immunology"},{"key":"2570_CR13","first-page":"131","volume":"22","author":"SH Kim","year":"2005","unstructured":"Kim, S. H., S. Y. Han, T. Azam, D. Y. Yoon, and C. A. Dinarello. 2005. Interleukin-32: a cytokine and inducer of TNFalpha. Immunity 22:131\u2013142.","journal-title":"Immunity"},{"key":"2570_CR14","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1016\/j.jaci.2010.01.016","volume":"125","author":"N Meyer","year":"2010","unstructured":"Meyer, N., M. Zimmermann, S. Burgler, C. Bassin, S. Woehrl, K. Moritz, C. Rhyner, P. Indermitte, P. Schmid-Grendelmeier, M. Akdis, G. Menz, and C.A. Akdis. 2010. IL-32 is expressed by human primary keratinocytes and modulates keratinocyte apoptosis in atopic dermatitis. Journal of Allergy and Clinical Immunology 125: 858\u201365 e10.","journal-title":"Journal of Allergy and Clinical Immunology"},{"key":"2570_CR15","doi-asserted-by":"publisher","first-page":"65825","DOI":"10.18632\/oncotarget.11669","volume":"7","author":"J Lee","year":"2016","unstructured":"Lee, J., K. E. Kim, S. Cheon, J. H. Song, Y. Houh, T. S. Kim, M. Gil, K. J. Lee, S. Kim, D. Kim, D. Y. Hur, Y. Yang, S. I. Bang, H. J. Park, and D. Cho. 2016. Interleukin-32alpha induces migration of human melanoma cells through downregulation of E-cadherin. Oncotarget 7:65825\u201365836.","journal-title":"Oncotarget"},{"key":"2570_CR16","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1007\/s11626-997-0021-6","volume":"33","author":"IC Le Poole","year":"1997","unstructured":"Le Poole, I. C., F. M. van den Berg, R. M. van den Wijngaard, D. A. Galloway, P. J. van Amstel, A. A. Buffing, H. L. Smits, W. Westerhof, and P. K. Das. 1997. Generation of a human melanocyte cell line by introduction of HPV16 E6 and E7 genes. In Vitro Cellular And Developmental Biology. Animal 33:42\u201349.","journal-title":"In Vitro Cellular And Developmental Biology. Animal"},{"key":"2570_CR17","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1290\/1071-2690(2000)036<0309:PAIHVM>2.0.CO;2","volume":"36","author":"IC Le Poole","year":"2000","unstructured":"Le Poole, I. C., R. E. Boissy, R. Sarangarajan, J. Chen, J. J. Forristal, P. Sheth, W. Westerhof, G. Babcock, P. K. Das, and C. B. Saelinger. 2000. PIG3V, an immortalized human vitiligo melanocyte cell line, expresses dilated endoplasmic reticulum. In Vitro Cellular And Developmental Biology. Animal 36:309\u2013319.","journal-title":"In Vitro Cellular And Developmental Biology. Animal"},{"key":"2570_CR18","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s13619-022-00132-9","volume":"11","author":"D Chen","year":"2022","unstructured":"Chen, D., Z. Xu, J. Cui, and T. Chen. 2022. A mouse model of vitiligo based on endogenous auto-reactive CD8\u2009+\u2009T cell targeting skin melanocyte. Cell Regen 11:31.","journal-title":"Cell Regen"},{"key":"2570_CR19","doi-asserted-by":"publisher","first-page":"6468","DOI":"10.1158\/0008-5472.CAN-07-1264","volume":"67","author":"P Zhang","year":"2007","unstructured":"Zhang, P., A. L. Cote, V. C. de Vries, E. J. Usherwood, and M. J. Turk. 2007. Induction of postsurgical tumor immunity and T-cell memory by a poorly immunogenic tumor. Cancer Research 67:6468\u20136476.","journal-title":"Cancer Research"},{"key":"2570_CR20","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.jid.2023.08.006","volume":"144","author":"EJ Lee","year":"2024","unstructured":"Lee, E. J., J. Y. Kim, J. H. Yeo, S. Park, Y. J. Bae, I. J. Kwon, S. H. Seong, J. Lee, and S. H. Oh. 2024. ISG15-USP18 Dysregulation by Oxidative Stress Promotes IFN-gamma Secretion from CD8\u2009+\u2009T Cells in Vitiligo. The Journal Of Investigative Dermatology 144:273\u2013283. e11.","journal-title":"The Journal Of Investigative Dermatology"},{"key":"2570_CR21","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/s41573-018-0008-x","volume":"18","author":"A Cuadrado","year":"2019","unstructured":"Cuadrado, A., A. I. Rojo, G. Wells, J. D. Hayes, S. P. Cousin, W. L. Rumsey, O. C. Attucks, S. Franklin, A. L. Levonen, T. W. Kensler, and A. T. Dinkova-Kostova. 2019. Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases. Nature Reviews. Drug Discovery 18:295\u2013317.","journal-title":"Nature Reviews. Drug Discovery"},{"key":"2570_CR22","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1093\/carcin\/bgv172","volume":"37","author":"B Heinhuis","year":"2016","unstructured":"Heinhuis, B., T. S. Plantinga, G. Semango, B. Kusters, M. G. Netea, C. A. Dinarello, J. W. A. Smit, R. T. Netea-Maier, and L. A. B. Joosten. 2016. Alternatively spliced isoforms of IL-32 differentially influence cell death pathways in cancer cell lines. Carcinogenesis 37:197\u2013205.","journal-title":"Carcinogenesis"},{"key":"2570_CR23","doi-asserted-by":"publisher","first-page":"3298","DOI":"10.1073\/pnas.0511233103","volume":"103","author":"LA Joosten","year":"2006","unstructured":"Joosten, L. A., M. G. Netea, S. H. Kim, D. Y. Yoon, B. Oppers-Walgreen, T. R. Radstake, P. Barrera, F. A. van de Loo, C. A. Dinarello, and W. B. van den Berg. 2006. IL-32, a proinflammatory cytokine in rheumatoid arthritis. Proc Natl Acad Sci U S A 103:3298\u20133303.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2570_CR24","doi-asserted-by":"publisher","first-page":"1264236","DOI":"10.3389\/fimmu.2023.1264236","volume":"14","author":"A Wallimann","year":"2023","unstructured":"Wallimann, A., and M. Schenk. 2023. IL-32 as a potential biomarker and therapeutic target in skin inflammation. Frontiers In Immunology 14:1264236.","journal-title":"Frontiers In Immunology"},{"key":"2570_CR25","first-page":"865","volume":"20","author":"D Kempuraj","year":"2010","unstructured":"Kempuraj, D., P. Conti, M. Vasiadi, K. D. Alysandratos, M. Tagen, D. Kalogeromitros, T. Kourelis, S. Gregoriou, M. Makris, N. G. Stavrianeas, and T. C. Theoharides. 2010. IL-32 is increased along with tryptase in lesional psoriatic skin and is up-regulated by substance P in human mast cells. European Journal Of Dermatology : Ejd 20:865\u2013867.","journal-title":"European Journal Of Dermatology : Ejd"},{"key":"2570_CR26","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1111\/exd.12918","volume":"25","author":"J Fuentes-Duculan","year":"2016","unstructured":"Fuentes-Duculan, J., N. Gulati, K. M. Bonifacio, N. Kunjravia, X. Zheng, M. Suarez-Farinas, A. Shemer, E. Guttman-Yassky, and J. G. Krueger. 2016. Biomarkers of alopecia areata disease activity and response to corticosteroid treatment. Experimental Dermatology 25:282\u2013286.","journal-title":"Experimental Dermatology"},{"key":"2570_CR27","doi-asserted-by":"publisher","first-page":"e449","DOI":"10.1111\/jdv.14274","volume":"31","author":"N Kitayama","year":"2017","unstructured":"Kitayama, N., A. Otsuka, Y. Nonomura, C. Nakashima, T. Honda, and K. Kabashima. 2017. Decrease in serum IL-32 level in patients with atopic dermatitis after cyclosporine treatment. Journal of the European Academy of Dermatology and Venereology 31: e449\u2013e450.","journal-title":"Journal of the European Academy of Dermatology and Venereology"},{"key":"2570_CR28","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1111\/bjd.15458","volume":"177","author":"R Thomi","year":"2017","unstructured":"Thomi, R., D. Yerly, N. Yawalkar, D. Simon, C. Schlapbach, and R. E. Hunger. 2017. Interleukin-32 is highly expressed in lesions of hidradenitis suppurativa. British Journal Of Dermatology 177:1358\u20131366.","journal-title":"British Journal Of Dermatology"},{"key":"2570_CR29","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1093\/bjd\/ljaf041","volume":"193","author":"J Gay-Mimbrera","year":"2025","unstructured":"Gay-Mimbrera, J., D. Lozano-Ojalvo, P. J. Gomez-Arias, I. Rivera-Ruiz, M. Aguilar-Luque, C. Mochon-Jimenez, E. Andujar Pulido, M. Perez-Alegre, E. Guttman-Yassky, and J. Ruano. 2025. Comprehensive single-cell chromatin and transcriptomic profiling of peripheral immune cells in nonsegmental vitiligo. British Journal Of Dermatology 193:115\u2013124.","journal-title":"British Journal Of Dermatology"},{"key":"2570_CR30","doi-asserted-by":"publisher","first-page":"201264","DOI":"10.1016\/j.humgen.2024.201264","volume":"39","author":"AGA Farag","year":"2024","unstructured":"Farag, A. G. A., M. A. E. M. Shoeib, RMAE-S. Koutb, SE-S. Soliman, and M. M. M. Ghanem. 2024. IL32:A novel pro-inflammatory cytokine involved in non-segmental vitiligo pathogenesis. Human Gene 39:201264.","journal-title":"Human Gene"},{"key":"2570_CR31","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/imr.12369","volume":"269","author":"JE Harris","year":"2016","unstructured":"Harris, J. E. 2016. Cellular stress and innate inflammation in organ-specific autoimmunity: lessons learned from vitiligo. Immunological Reviews 269:11\u201325.","journal-title":"Immunological Reviews"},{"key":"2570_CR32","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1007\/s00125-022-05654-0","volume":"65","author":"R Dettmer","year":"2022","unstructured":"Dettmer, R., I. Niwolik, K. Cirksena, T. Yoshimoto, Y. Tang, I. Mehmeti, E. Gurgul-Convey, and O. Naujok. 2022. Proinflammatory cytokines induce rapid, NO-independent apoptosis, expression of chemotactic mediators and interleukin-32 secretion in human pluripotent stem cell-derived beta cells. Diabetologia 65:829\u2013843.","journal-title":"Diabetologia"},{"key":"2570_CR33","doi-asserted-by":"publisher","first-page":"567","DOI":"10.3892\/etm.2022.11504","volume":"24","author":"Y Li","year":"2022","unstructured":"Li, Y., and Z. Wang. 2022. Interleukin 32 participates in cardiomyocyte-induced oxidative stress, inflammation and apoptosis during hypoxia\/reoxygenation via the NOD2\/NOX2\/MAPK signaling pathway. Exp Ther Med 24:567.","journal-title":"Exp Ther Med"},{"key":"2570_CR34","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/s11011-019-00530-0","volume":"35","author":"H Yin","year":"2020","unstructured":"Yin, H., M. Wu, and Y. Jia. 2020. Knockdown of IL-32 protects PC12 cells against oxygen-glucose deprivation\/reoxygenation-induced injury via activation of Nrf2\/NF-kappaB pathway. Metabolic Brain Disease 35:363\u2013371.","journal-title":"Metabolic Brain Disease"},{"key":"2570_CR35","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1038\/jid.2014.152","volume":"134","author":"Z Jian","year":"2014","unstructured":"Jian, Z., K. Li, P. Song, G. Zhu, L. Zhu, T. Cui, B. Liu, L. Tang, X. Wang, G. Wang, T. Gao, and C. Li. 2014. Impaired activation of the Nrf2-ARE signaling pathway undermines H2O2-induced oxidative stress response: a possible mechanism for melanocyte degeneration in vitiligo. The Journal Of Investigative Dermatology 134:2221\u20132230.","journal-title":"The Journal Of Investigative Dermatology"},{"key":"2570_CR36","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1038\/jid.2011.56","volume":"131","author":"Z Jian","year":"2011","unstructured":"Jian, Z., K. Li, L. Liu, Y. Zhang, Z. Zhou, C. Li, and T. Gao. 2011. Heme oxygenase-1 protects human melanocytes from H2O2-induced oxidative stress via the Nrf2-ARE pathway. The Journal Of Investigative Dermatology 131:1420\u20131427.","journal-title":"The Journal Of Investigative Dermatology"},{"key":"2570_CR37","first-page":"14","volume":"14","author":"NE Sorour","year":"2021","unstructured":"Sorour, N. E., H. M. Abd El-Kareem, A. E. Ibrahim, and R. M. Salem. 2021. Nuclear Factor Erythroid-2-related Factor 2 Gene Polymorphisms in Vitiligo. J Clin Aesthet Dermatol 14:14\u201317.","journal-title":"J Clin Aesthet Dermatol"},{"key":"2570_CR38","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/j.freeradbiomed.2024.10.303","volume":"225","author":"Y Le","year":"2024","unstructured":"Le, Y., M.M. Geng, B.Q. Dong, L.F. Luo, S. Jiang, I.C. Le Poole, and T.C. Lei. 2024. Increased splicing of CXCR3 isoform B (CXCR3B) by impaired NRF2 signaling leads to melanocyte apoptosis in active vitiligo. Free Radical Biology & Medicine 225: 687\u2013698.","journal-title":"Free Radical Biology & Medicine"},{"issue":"Suppl 1","key":"2570_CR39","first-page":"E23","volume":"53","author":"ES Park","year":"2014","unstructured":"Park, E. S., J. M. Yoo, H. S. Yoo, D. Y. Yoon, Y. P. Yun, and J. Hong. 2014. IL-32gamma enhances TNF-alpha-induced cell death in colon cancer. Molecular Carcinogenesis 53(Suppl 1):E23\u201335.","journal-title":"Molecular Carcinogenesis"},{"key":"2570_CR40","doi-asserted-by":"crossref","unstructured":"Zhang, J., X. Sun, L. Zhong, and B. Shen. 2021. IL-32 exacerbates adenoid hypertrophy via activating NLRP3-mediated cell pyroptosis, which promotes inflammation. Mol Med Rep 23:226.","DOI":"10.3892\/mmr.2021.11865"},{"key":"2570_CR41","doi-asserted-by":"crossref","unstructured":"Hlaca, N., T. Zagar, M. Kastelan, I. Brajac, and L. Prpic-Massari. 2022. Current Concepts of Vitiligo Immunopathogenesis. Biomedicines 10:1639.","DOI":"10.3390\/biomedicines10071639"},{"key":"2570_CR42","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.jid.2016.09.016","volume":"137","author":"JM Richmond","year":"2017","unstructured":"Richmond, J.M., D.S. Bangari, K.I. Essien, S.D. Currimbhoy, J.R. Groom, A.G. Pandya, M.E. Youd, A.D. Luster, and J.E. Harris. 2017. Keratinocyte-derived chemokines orchestrate T-cell positioning in the epidermis during vitiligo and may serve as biomarkers of disease. Journal of Investigative Dermatology 137: 350\u2013358.","journal-title":"Journal of Investigative Dermatology"},{"key":"2570_CR43","doi-asserted-by":"publisher","first-page":"223ra23","DOI":"10.1126\/scitranslmed.3007811","volume":"6","author":"M Rashighi","year":"2014","unstructured":"Rashighi, M., P. Agarwal, J. M. Richmond, T. H. Harris, K. Dresser, M. W. Su, Y. Zhou, A. Deng, C. A. Hunter, A. D. Luster, and J. E. Harris. 2014. CXCL10 is critical for the progression and maintenance of depigmentation in a mouse model of vitiligo. Science Translational Medicine 6:223ra23.","journal-title":"Science Translational Medicine"},{"key":"2570_CR44","doi-asserted-by":"publisher","first-page":"R120","DOI":"10.1186\/ar3850","volume":"14","author":"M Nakayama","year":"2012","unstructured":"Nakayama, M., Y. Niki, T. Kawasaki, Y. Takeda, K. Horiuchi, A. Sasaki, Y. Okada, K. Umezawa, H. Ikegami, Y. Toyama, and T. Miyamoto. 2012. Enhanced susceptibility to lipopolysaccharide-induced arthritis and endotoxin shock in interleukin-32 alpha transgenic mice through induction of tumor necrosis factor alpha. Arthritis Res Ther 14:R120.","journal-title":"Arthritis Res Ther"},{"key":"2570_CR45","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.jaci.2019.12.905","volume":"146","author":"YS Lee","year":"2020","unstructured":"Lee, Y. S., S. B. Han, H. J. Ham, J. H. Park, J. S. Lee, D. Y. Hwang, Y. S. Jung, D. Y. Yoon, and J. T. Hong. 2020. IL-32gamma suppressed atopic dermatitis through inhibition of miR-205 expression via inactivation of nuclear factor-kappa B. The Journal Of Allergy And Clinical Immunology 146:156\u2013168.","journal-title":"The Journal Of Allergy And Clinical Immunology"}],"container-title":["Inflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10753-026-02570-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-026-02570-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-026-02570-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T03:50:02Z","timestamp":1791431402000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10753-026-02570-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,15]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2570"],"URL":"https:\/\/doi.org\/10.1007\/s10753-026-02570-y","relation":{},"ISSN":["1573-2576"],"issn-type":[{"value":"1573-2576","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,15]]},"assertion":[{"value":"31 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was performed based on the principles of the Declaration of Helsinki. Approved by the Ethics Committee of the Hospital of Skin Diseases, Chinese Academy of Medical Sciences & Peking Union Medical College. All animal experimental protocols were approved by the Ethics Committee of Hospital of Skin Diseases, Chinese Academy of Medical Sciences & Peking Union Medical College.","order":1,"name":"Ethics","label":"Ethics Approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was obtained from the patients.","order":2,"name":"Ethics","label":"Consent to Participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"197"}}